Previsioni di mercato per la terapia dell\'osteoartrosi in Medio Oriente e Africa fino al 2030 - Analisi regionale - per tipo di terapia (stimolazione elettrica transcutanea dei nervi (TENS), terapia occupazionale, terapia fisica, terapia al plasma ricco di piastrine e frazione vascolare stromale, proloterapia e altre), indicazione della malattia (Osteoartrite del ginocchio, Osteoartrite della colonna vertebrale, Osteoartrite del piede e della caviglia, Osteoartrite della spalla, Osteoartrite della mano e altri) e Utente finale (Ospedali e cliniche, Cliniche specialistiche, Centri chirurgici ambulatoriali, Assistenza domiciliare e Altri)
La crescente prevalenza dell\'osteoartrite rafforza il mercato della terapia per l\'osteoartrosi in Medio Oriente e Africa.
A livello globale, l\'OA colpisce più di 500 milioni di persone, pari a 7 % della popolazione mondiale secondo il rapporto del CDC. Rappresenta una delle principali cause di disabilità a lungo termine. Inoltre, l’artrosi è più diffusa anche tra gli atleti e le persone che subiscono lesioni o traumi articolari. Inoltre, è più diffusa tra le donne, rappresentando il 60% dei casi di osteoartrosi a livello mondiale. Secondo il rapporto dell’Organizzazione Mondiale della Sanità (OMS), l’artrosi è più diffusa tra la popolazione anziana. Inoltre, l’OA può colpire chiunque, ma la condizione è più comune negli adulti di età superiore ai 40 anni. Inoltre, il rapporto dell\'Organizzazione Mondiale della Sanità rivela inoltre che circa il 73% delle persone che vivono con OA hanno più di 55 anni e il 60% sono donne. Pertanto, con la crescente prevalenza dell’OA, nuove opzioni terapeutiche come la terapia biologica stanno guadagnando attenzione in tutto il mondo. La terapia con plasma ricco di piastrine (PRP) è un esempio emerso come trattamento promettente per i pazienti affetti da OA. Il PRP migliora il recupero dei tessuti catalizzando i naturali processi di guarigione e riparazione dei tessuti del corpo.
La stimolazione elettrica nervosa transcutanea (TENS) è un altro esempio di opzione terapeutica per il trattamento dell\'OA. La TENS aiuta a minimizzare i dolori acuti e cronici riducendo la necessità di farmaci. Pertanto, la crescente prevalenza dell’OA accelera la domanda di opzioni terapeutiche innovative, riducendo la dipendenza dai farmaci nei prossimi anni.
Panoramica del mercato della terapia per l\'osteoartrite in Medio Oriente e Africa
La regione del Medio Oriente e dell\'Africa è segmentata come Arabia Saudita, Sud Africa, Emirati Arabi Uniti e il resto dei paesi del Medio Oriente e dell\'Africa. L’aumento dei tassi di obesità, l’alterazione degli stili di vita e dei modelli alimentari sono i fattori più influenti responsabili dell’accelerazione della domanda di farmaci per l’osteoartrosi nella regione del Medio Oriente e dell’Africa. Secondo il rapporto del National Institute of Health (NIH), l’artrosi è la forma più diffusa di artrite. In Sud Africa, in ambito urbano, rappresenta il 55,1%; negli ambienti rurali variava dal 29,5% al 29,7%, arrivando fino all\'82,7% tra la popolazione con più di 65 anni. I medici suggeriscono diverse opzioni terapeutiche per il trattamento dell’osteoartrosi. Il trattamento comprende farmaci antinfiammatori non steroidei (FANS) come l’ibuprofene. Pertanto, la disponibilità di opzioni di trattamento per l’artrosi è il principale fattore responsabile della crescita del mercato nel periodo 2022-2030.
Previsioni e entrate del mercato della terapia per l\'osteoartrite in Medio Oriente e Africa fino al 2030 (milioni di dollari)
Segmentazione del mercato della terapia per l\'osteoartrite in Medio Oriente e Africa
Terapia per l\'osteoartrite in Medio Oriente e Africa il mercato è classificato in tipo di terapia, indicazioni di malattia, utente finale e paese.
In base al tipo di terapia, il mercato della terapia per l\'osteoartrite in Medio Oriente e Africa è segmentato in stimolazione nervosa elettrica transcutanea (TENS), terapia occupazionale, terapia fisica, terapia con plasma ricco di piastrine (PRP) e frazione vascolare stromale, proloterapia , e altri. Il segmento della terapia fisica ha detenuto la quota di mercato maggiore nel 2022.
In termini di indicazioni di malattia, il mercato della terapia per l\'osteoartrite in Medio Oriente e Africa è segmentato in osteoartrite del ginocchio, osteoartrite della colonna vertebrale, osteoartrite del piede e della caviglia, osteoartrite della spalla, osteoartrite della mano. osteoartrite e altri. Il segmento dell\'osteoartrite del ginocchio ha detenuto la quota maggiore del mercato della terapia per l\'osteoartrosi in Medio Oriente e Africa nel 2022.
In base all\'utente finale, il mercato della terapia per l\'osteoartrosi in Medio Oriente e Africa è classificato in ospedali e cliniche, cliniche specialistiche, chirurgia ambulatoriale centro, assistenza domiciliare e altri. Il segmento dell\'assistenza domiciliare ha detenuto la quota maggiore del mercato della terapia per l\'osteoartrosi in Medio Oriente e Africa nel 2022.
Per paese, il mercato della terapia per l\'osteoartrosi in Medio Oriente e Africa è segmentato in Sud Africa, Arabia Saudita, Emirati Arabi Uniti e Resto del Medio Oriente e dell\'Africa. Il Sud Africa ha dominato la quota di mercato della terapia per l\'osteoartrosi in Medio Oriente e Africa nel 2022.
Estar Technologies Ltd, Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc e Medi GmbH & Co KG sono alcuni dei le aziende leader che operano nel mercato della terapia dell’osteoartrosi in Medio Oriente e Africa.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Osteoarthritis Therapy Market Landscape
4.1 Pipeline Analysis
4.1.1 Clinical Trial Pipeline Analysis
5. Middle East & Africa Osteoarthritis Therapy Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Osteoarthritis
5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
5.2.1 Product Recall
5.3 Market Opportunities
5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:
6. Osteoarthritis Therapy Market - Middle East & Africa Market Analysis
6.1 Overview
6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
7. Middle East & Africa Osteoarthritis Therapy Market Analysis - by Therapy Type
7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
7.2.1 Overview
7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
7.3.1 Overview
7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
7.4.1 Overview
7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
7.5.1 Overview
7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
7.6.1 Overview
7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Osteoarthritis Therapy Market Analysis - by Disease Indication
8.1 Overview
8.2 Knee Osteoarthritis
8.2.1 Overview
8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
8.3.1 Overview
8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
8.4.1 Overview
8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
8.5.1 Overview
8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
8.6.1 Overview
8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Osteoarthritis Therapy Market Analysis - by End User
9.1 Overview
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
9.3.1 Overview
9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Osteoarthritis Therapy Market - Country Analysis
10.1 Middle East & Africa Market Overview
10.1.1 Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
10.1.1.1 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 South Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.1.4 South Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.1.5 South Africa: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.2.4 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.2.5 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.3 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.3.4 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.3.5 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.4 Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.4.4 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.4.5 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Estar Technologies Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Zimmer Biomet Holdings Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 DePuy Synthes Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bioventus Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Omron Healthcare Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medi GmbH & Co KG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the Insight Partners
List of Tables
Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 13. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 14. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Organic Developments Done by Companies
Table 16. Inorganic Developments Done by Companies
List of Figures
Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Middle East & Africa: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)
Figure 26. Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Growth Strategies in the Osteoarthritis Therapy Market
1. Estar Technologies Ltd
2. Zimmer Biomet Holdings Inc
3. DePuy Synthes Inc
4. Bioventus Inc
5. Omron Healthcare Inc
6. Medi GmbH & Co KG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa osteoarthritis therapy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa osteoarthritis therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa osteoarthritis therapy market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.